Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/publications/10295-final-analysis-of-the-prospective-wsg-ago-ec-doc-versus-fec-phase-iii-trial-in-intermediate-risk-pn1-early-breast-cancer-efficacy-and-predictive-value-of-ki67-expression